109 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34806235 | Impact of α-synuclein spreading on the nigrostriatal dopaminergic pathway depends on the onset of the pathology. | 2022 Mar | 4 |
2 | 35038583 | Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotype. | 2022 Apr 6 | 2 |
3 | 35075150 | MicroRNA-181a-2-3p shuttled by mesenchymal stem cell-secreted extracellular vesicles inhibits oxidative stress in Parkinson's disease by inhibiting EGR1 and NOX4. | 2022 Jan 24 | 1 |
4 | 35163729 | Up and Down γ-Synuclein Transcription in Dopamine Neurons Translates into Changes in Dopamine Neurotransmission and Behavioral Performance in Mice. | 2022 Feb 4 | 1 |
5 | 35214176 | Focused Ultrasound-Induced Blood-Brain Barrier Opening Enhanced α-Synuclein Expression in Mice for Modeling Parkinson's Disease. | 2022 Feb 18 | 1 |
6 | 35280925 | Modulation of miR-181 influences dopaminergic neuronal degeneration in a mouse model of Parkinson's disease. | 2022 Jun 14 | 1 |
7 | 33429895 | Dopamine D2 Long Receptors Are Critical for Caveolae-Mediated α-Synuclein Uptake in Cultured Dopaminergic Neurons. | 2021 Jan 8 | 3 |
8 | 33713002 | Pharmacological Inhibition of Brain EGFR Activation By a BBB-penetrating Inhibitor, AZD3759, Attenuates α-synuclein Pathology in a Mouse Model of α-Synuclein Propagation. | 2021 Apr | 3 |
9 | 33727096 | An extended release GLP-1 analogue increases α-synuclein accumulation in a mouse model of prodromal Parkinson's disease. | 2021 Jul | 1 |
10 | 33805843 | Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice. | 2021 Mar 13 | 2 |
11 | 33935654 | Striatal Dopamine Transporter Function Is Facilitated by Converging Biology of α-Synuclein and Cholesterol. | 2021 | 8 |
12 | 34083630 | Alpha-synuclein increases in rodent and human spinal cord injury and promotes inflammation and tissue loss. | 2021 Jun 3 | 1 |
13 | 34307368 | Alpha-Synuclein Pathology Coincides With Increased Number of Early Stage Neural Progenitors in the Adult Hippocampus. | 2021 | 1 |
14 | 34408150 | α-Synuclein-induced dysregulation of neuronal activity contributes to murine dopamine neuron vulnerability. | 2021 Aug 18 | 3 |
15 | 34509608 | A novel glucosylceramide synthase inhibitor attenuates alpha synuclein pathology and lysosomal dysfunction in preclinical models of synucleinopathy. | 2021 Nov | 1 |
16 | 34716339 | Microglia-specific overexpression of α-synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity. | 2021 Oct 29 | 1 |
17 | 31768670 | Loss of fragile X mental retardation protein precedes Lewy pathology in Parkinson's disease. | 2020 Feb | 1 |
18 | 31837424 | Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded α-synuclein inclusions. | 2020 Feb | 1 |
19 | 32865008 | IGF-1 inhibits MPTP/MPP+-induced autophagy on dopaminergic neurons through the IGF-1R/PI3K-Akt-mTOR pathway and GPER. | 2020 Oct 1 | 1 |
20 | 32865527 | Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons. | 2020 Aug 16 | 5 |
21 | 32964492 | GDNF/RET Signaling Pathway Activation Eliminates Lewy Body Pathology in Midbrain Dopamine Neurons. | 2020 Dec | 3 |
22 | 30496735 | Development of FABP3 ligands that inhibit arachidonic acid-induced α-synuclein oligomerization. | 2019 Mar 15 | 2 |
23 | 30592597 | Impact of Dopamine Oxidation on Dopaminergic Neurodegeneration. | 2019 Feb 20 | 3 |
24 | 30633814 | The usual suspects, dopamine and alpha-synuclein, conspire to cause neurodegeneration. | 2019 Feb | 3 |
25 | 30741691 | The Amphetamine Induced Rotation Test: A Re-Assessment of Its Use as a Tool to Monitor Motor Impairment and Functional Recovery in Rodent Models of Parkinson's Disease. | 2019 | 1 |
26 | 30890737 | Unbalanced calcium channel activity underlies selective vulnerability of nigrostriatal dopaminergic terminals in Parkinsonian mice. | 2019 Mar 19 | 1 |
27 | 31165254 | Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model. | 2019 Oct | 1 |
28 | 31420910 | Enhanced mitochondrial inhibition by 3,4-dihydroxyphenyl-acetaldehyde (DOPAL)-oligomerized α-synuclein. | 2019 Dec | 2 |
29 | 31445131 | Total glucosides of paeony (TGP) extracted from Radix Paeoniae Alba exerts neuroprotective effects in MPTP-induced experimental parkinsonism by regulating the cAMP/PKA/CREB signaling pathway. | 2019 Dec 5 | 1 |
30 | 29524599 | A stress-enhanced model for discovery of disease-modifying gene: Ece1-suppresses the toxicity of α-synuclein A30P. | 2018 Jun | 1 |
31 | 29559809 | The Convergence of Dopamine and α-Synuclein: Implications for Parkinson's Disease. | 2018 | 6 |
32 | 29785351 | Genetic inactivation of alpha-synuclein affects embryonic development of dopaminergic neurons of the substantia nigra, but not the ventral tegmental area, in mouse brain. | 2018 | 2 |
33 | 30127535 | α-Synuclein interacts directly but reversibly with psychosine: implications for α-synucleinopathies. | 2018 Aug 20 | 1 |
34 | 30127714 | Palmitic Acid-Enriched Diet Increases α-Synuclein and Tyrosine Hydroxylase Expression Levels in the Mouse Brain. | 2018 | 1 |
35 | 30503521 | Parkinson-Associated SNCA Enhancer Variants Revealed by Open Chromatin in Mouse Dopamine Neurons. | 2018 Dec 6 | 1 |
36 | 30622456 | Could α-Synuclein Modulation of Insulin and Dopamine Identify a Novel Link Between Parkinson's Disease and Diabetes as Well as Potential Therapies? | 2018 | 1 |
37 | 28053029 | Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease. | 2017 Jan 4 | 1 |
38 | 28637871 | Phosphorylation at serine 31 targets tyrosine hydroxylase to vesicles for transport along microtubules. | 2017 Aug 25 | 1 |
39 | 28920936 | Dopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration. | 2017 Nov | 4 |
40 | 29200905 | MPTP-induced vulnerability of dopamine neurons in A53T α-synuclein overexpressed mice with the potential involvement of DJ-1 downregulation. | 2017 Nov | 1 |
41 | 26880341 | The novel adaptive rotating beam test unmasks sensorimotor impairments in a transgenic mouse model of Parkinson's disease. | 2016 May 1 | 1 |
42 | 27161373 | Exogenous α-Synuclein Monomers Alter Dopamine Metabolism in Murine Brain. | 2016 Aug | 2 |
43 | 27614017 | Combinational losses of synucleins reveal their differential requirements for compensating age-dependent alterations in motor behavior and dopamine metabolism. | 2016 Oct | 1 |
44 | 25446742 | Noradrenergic and serotonergic neurochemistry arising from intranasal inoculation with α-synuclein aggregates which incite parkinsonian-like symptoms. | 2015 Feb 15 | 4 |
45 | 25500798 | The Parkinson's disease-related protein DJ-1 protects dopaminergic neurons in vivo and cultured cells from alpha-synuclein and 6-hydroxydopamine toxicity. | 2015 | 1 |
46 | 25567480 | Protein phosphatase 2A is involved in the tyrosine hydroxylase phosphorylation regulated by α-synuclein. | 2015 Mar | 1 |
47 | 25714663 | Evaluation of an α synuclein sensitized dendritic cell based vaccine in a transgenic mouse model of Parkinson disease. | 2015 | 1 |
48 | 25852303 | Differential effects of dopamine signalling on long-term memory formation and consolidation in rodent brain. | 2015 | 1 |
49 | 25853296 | PGC-1α activity in nigral dopamine neurons determines vulnerability to α-synuclein. | 2015 Apr 1 | 1 |
50 | 25967550 | α-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons. | 2015 Jul 1 | 4 |